Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis.

Authors

Sarah F Ackley
Scott C Zimmerman
Willa D Brenowitz
Eric J Tchetgen Tchetgen
Audra L Gold
Jennifer J Manly
Elizabeth Rose Mayeda
Teresa J Filshtein
Melinda C. Power, George Washington University
Fanny M Elahi
Adam M Brickman
M Maria Glymour

Document Type

Journal Article

Publication Date

2-25-2021

Journal

BMJ

Volume

372

DOI

10.1136/bmj.n156

Keywords

Alzheimer Disease; Amyloid beta-Peptides; Cognition; Cognitive Dysfunction; Humans; Randomized Controlled Trials as Topic; Research Design

APA Citation

Ackley, S., Zimmerman, S., Brenowitz, W., Tchetgen Tchetgen, E., Gold, A., Manly, J., Mayeda, E., Filshtein, T., Power, M. C., Elahi, F., Brickman, A., & Glymour, M. (2021). Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis.. BMJ, 372 (). http://dx.doi.org/10.1136/bmj.n156

Peer Reviewed

1